Tomoyuki Matsuda Selected Research

Chemoradiotherapy

2/2018

Rebamipide suppresses 5-fluorouracil-induced cell death via the activation of Akt/mTOR pathway and regulates the expression of Bcl-2 family proteins.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tomoyuki Matsuda Research Topics

Disease

3	Cardiac Arrhythmias (Arrythmia) 01/2011 - 05/2005
2	Acute Lung Injury 03/2008 - 12/2004
2	Inflammation (Inflammations) 03/2008 - 12/2004
2	Atrial Fibrillation 05/2005 - 02/2002
1	Stroke (Strokes) 10/2023
1	Stomatitis 02/2018
1	Mucositis 02/2018
1	Lung Injury 03/2008
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 03/2008
1	Cross Infection (Nosocomial Infection) 02/2007

Drug/Important Bio-Agent (IBA)

4	NIP142IBA 01/2011 - 02/2002
4	BenzopyransIBA 01/2011 - 02/2002
1	rebamipideIBA 02/2018
1	Potassium Channels (Potassium Channel)IBA 01/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2008
1	HMGB2 ProteinIBA 12/2004
1	Proteins (Proteins, Gene)FDA Link 12/2004
1	HMGB ProteinsIBA 12/2004
1	HMGB1 Protein (HMG1)IBA 12/2004

Therapy/Procedure

1	Activities of Daily Living (ADL) 10/2023
1	Drug Therapy (Chemotherapy) 02/2018
1	Chemoradiotherapy 02/2018
1	Anesthesia 02/2007